Article Text

other Versions

Download PDFPDF
Prognostic value of prenatally detected small or absent fetal stomach with particular reference to oesophageal atresia
  1. Lucinda Tullie1,
  2. Nigel J Hall1,2,
  3. David M Burge1,
  4. David T Howe3,
  5. Melanie Drewett1,
  6. Diana Wellesley4
  1. 1Department of Paediatric Surgery and Urology, Southampton Children's Hospital, Southampton, UK
  2. 2University Surgery Unit, Faculty of Medicine, University of Southampton, Southampton, UK
  3. 3Department of Maternal and Fetal Medicine, University Hospital Southampton, Southampton, UK
  4. 4Wessex Clinical Genetic Service, University Hospital Southampton, Southampton, UK
  1. Correspondence to Lucinda Tullie, Department of Paediatric Surgery and Urology, Southampton Children's Hospital, Southampton SO16 6YD, UK; ltullie{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Identification of a small or absent stomach during fetal anomaly screening may be indicative of a range of underlying pathologies, many of which carry implications for counselling, continuing the pregnancy and planning delivery. While oesophageal atresia (OA), with or without tracheoesophageal fistula (TOF), is one such diagnosis, the wide spectrum of outcomes of pregnancies with a small/absent stomach presents a significant challenge. In light of this, we reviewed all pregnancies in the Wessex AnteNatally Detected Anomaly (WANDA) registry from 1994 to 2015, in which a small/absent stomach had been identified on fetal sonograms, aiming to identify patterns and/or prognostic indicators which may improve outcome prediction.

WANDA is prospectively maintained, population-based and records details of all prenatally and postnatally detected, true …

View Full Text


  • Contributors LT: draft and revision of manuscript. NJH: study design, revision of manuscript and final approval. DMB, DTH, MD: data collection, revision of manuscript and final approval. DW: study design, data collection, draft and revision of manuscript and final approval.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.